Precision Medicine in Atopic Dermatitis: Where the Field Stands Now
A Dermatology Times review maps precision medicine's uneven progress in atopic dermatitis: targeted drugs are here, patient-level prediction is not yet.
Topic
Biomarkers
Topic
Biomarkers
Extracellular Vesicles Take Center Stage in Atopic Dermatitis Research
A Frontiers review positions extracellular vesicles as both inflammatory mediators in atopic dermatitis and engineered delivery v…
Precision Dermatology in Atopic Dermatitis: The Open Question
Clinicians debate what precision medicine can realistically deliver for atopic dermatitis, where targeted therapies now outnumber…
Ixekizumab–Tirzepatide Pair Moves Biomarkers in Psoriatic Obesity
Dermatology Times: ixekizumab plus tirzepatide shifted biomarkers in psoriasis patients with obesity. Detailed PASI, inflammatory…
UCLA Health spotlights dermatologist's skin-aging inquiry
UCLA Health publishes 'How do our bodies age? This dermatologist is looking to skin for answers,' a feature positioning cutaneous…
Rezpegaldesleukin Biomarker Data Take Late-Breaking Slot at EADV 2026
Biomarker data presented late-breaking at EADV Congress 2026 show rezpegaldesleukin produces early molecular responses across mul…
UCB's Galvokimig Advances in Atopic Dermatitis Pipeline
UCB's atopic dermatitis candidate galvokimig cleared transcriptomic and biomarker analyses, per The Dermatology Digest's AD Pipel…
Serum Proteomics Ties Distinct Signatures to Atopic Dermatitis Severity
Lally and colleagues report in Allergy that serum-proteomic profiling reveals distinct protein signatures linked to atopic dermat…
Rezpegaldesleukin Biomarker Data Show Early Immune Reset in AD
Week-2 serum biomarker shifts — rising IL-10 and TGFΒ1, falling TARC — predicted Week-16 EASI gains in rezpegaldesleukin-treated…
Nektar Presents Biomarker Data on Atopic Dermatitis Candidate
Nektar Therapeutics has presented biomarker data on its investigational atopic dermatitis drug, offering early pharmacologic insi…